BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27989901)

  • 1. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
    Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
    Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI.
    Liu HL; Chang TT; Yan FX; Li CH; Lin YS; Wong AM
    NMR Biomed; 2015 Jun; 28(6):642-9. PubMed ID: 25880892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of single- and dual-tracer pharmacokinetic modeling of dynamic contrast-enhanced MRI data using low, medium, and high molecular weight contrast agents.
    Orth RC; Bankson J; Price R; Jackson EF
    Magn Reson Med; 2007 Oct; 58(4):705-16. PubMed ID: 17899608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
    Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
    Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
    Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
    Li Y; Liu G; Lou X; Chen Z; Ma L
    Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of dynamic contrast-enhanced MRI contrast agent transfer constant K
    Dickie BR; Rose CJ; Kershaw LE; Withey SB; Carrington BM; Davidson SE; Hutchison G; West CML
    Br J Cancer; 2017 May; 116(11):1436-1443. PubMed ID: 28449009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of intravoxel contrast agent diffusion on the analysis of DCE-MRI data in realistic tissue domains.
    Woodall RT; Barnes SL; Hormuth DA; Sorace AG; Quarles CC; Yankeelov TE
    Magn Reson Med; 2018 Jul; 80(1):330-340. PubMed ID: 29115690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.
    Feng Y; Emerson L; Jeong EK; Parker DL; Lu ZR
    J Magn Reson Imaging; 2009 Aug; 30(2):401-6. PubMed ID: 19629979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T.
    Kim J; Moestue SA; Bathen TF; Kim E
    Tomography; 2019 Sep; 5(3):308-319. PubMed ID: 31572792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
    Delrue LJ; Casneuf V; Van Damme N; Blanckaert P; Peeters M; Ceelen WP; Duyck PC
    MAGMA; 2011 Aug; 24(4):225-32. PubMed ID: 21567161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of rat brain tumor kinetics using an intravascular MR contrast agent and DCE-MRI nested model selection.
    Chwang WB; Jain R; Bagher-Ebadian H; Nejad-Davarani SP; Iskander AS; VanSlooten A; Schultz L; Arbab AS; Ewing JR
    J Magn Reson Imaging; 2014 Nov; 40(5):1223-9. PubMed ID: 24421265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents.
    Ivanusa T; Beravs K; Medic J; Sersa I; Sersa G; Jevtic V; Demsar F; Mikac U
    Phys Med; 2007 Dec; 23(3-4):85-90. PubMed ID: 18061121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.